XML 17 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (122,071) $ (103,410)
Adjustments to reconcile net loss to cash flows from operating activities:    
Depreciation and amortization 2,873 2,571
Amortization of premium on available-for-sale securities, loss from sale of available-for-sale securities and non-cash interest 394 613
Loss on abandonment of patents 24 132
Stock-based compensation 13,665 20,086
Changes in operating assets and liabilities, net:    
Net increase in accounts receivable (5)  
Net (increase) decrease in other assets (394) 8,695
Net increase (decrease) in accounts payable, accrued expenses, deferred revenue and other liabilities 1,542 (566)
Net cash used in operating activities (103,972) (71,879)
Cash flows from investing activities:    
Purchase of property and equipment (1,587) (1,169)
Patent costs (768) (640)
Purchase of available-for-sale securities   (49,631)
Sale and maturity of available-for-sale securities 100,712 98,650
Net cash provided by investing activities 98,357 47,210
Cash flows from financing activities:    
Proceeds from borrowings, net of debt issuance costs   19,734
Repayments of long-term debt and notes payable (2,551) (49)
Proceeds from exercise of options, purchase of stock under the Employee Stock Purchase Program and sales of common stock 39,681 971
Net cash provided by financing activities 37,130 20,656
Increase (decrease) in cash and cash equivalents 31,515 (4,013)
Cash and cash equivalents:    
Beginning of period 80,304 73,551
End of period 111,819 69,538
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 828 37
Supplemental schedule of non-cash investing activities and financing activities:    
Property and equipment included in accrued expenses 99  
Accrual for senior secured term loan principal payment 833  
Accrual for debt issuance costs related to the senior secured term loan 400 540
Patent costs included in accrued expenses 259 170
Accrual for offering costs related to the June 2016 equity offering 170  
Shares withheld for taxes $ 104  
Capitalized interest   $ 99